ArticleAnnals of surgical oncology2022

Neoadjuvant versus Postoperative Chemoradiotherapy is Associated with Improved Survival for Patients with Resectable Gastric and Gastroesophageal Cancer.

Daniel W Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.